Cassava Sciences | 营业利润



Operating Profit 更改 日
Abbott USD 1.91B 41M 2024-12
Amgen USD 2.31B 182M 2024-12
Biogen USD 441.4M 24.4M 2024-12
Cassava Sciences USD -29487000 1.14M 2024-12
Eisai JPY 27.56B 13.14B 2024-12
Eli Lilly USD 5.15B 3.62B 2024-12
Geron USD -21757000 6.46M 2024-12
J&J USD 3.89B 549M 2024-12
Merck USD 4.3B 369M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD -409000000 5.57B 2024-12
Roche Holding CHF 4.39B 1.04B 2024-12



Cassava Sciences 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.